Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,000 shares at $42.41 ($848K) on 2023-08-22, disclosed to the SEC on 2023-08-23.
Scheduled sale ($848k) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.41 | 1,925 | $82K | 9.6% |
| 2 | $42.41 | 1,925 | $82K | 9.6% |
| 3 | $42.41 | 8,075 | $342K | 40.4% |
| 4 | $42.41 | 8,075 | $342K | 40.4% |
| Total | $42.41 avg | 20,000 | $848K | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |